BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1692 related articles for article (PubMed ID: 33554682)

  • 1. Latin American forum on immunization services during the COVID-19 pandemic.
    Ávila-Agüero ML; Ospina-Henao S; Pirez MC; Gentile Á; Araya S; Brea J; Mendoza L; Falleiros-Arlant LH
    Expert Rev Vaccines; 2021 Mar; 20(3):231-234. PubMed ID: 33554682
    [No Abstract]   [Full Text] [Related]  

  • 2. Risks of low vaccination coverage and strategies to prevent the resurgence of vaccine-preventable diseases in infants in the COVID-19 pandemic scenario: recommendations for Latin America and the Caribbean by the group of experts on infant immunization for Latin America.
    Avila Agüero ML; Castillo JBD; Falleiros-Arlant LH; Berezín E; de Moraes JC; Torres-Martínez C; Lopez EL; Castillo ME; Laris-Gonzalez A; Solorzano F; Gentile A; Torres Torretti JP; López-Medina E
    Expert Rev Vaccines; 2023; 22(1):1091-1101. PubMed ID: 37843489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns.
    Ho LL; Gurung S; Mirza I; Nicolas HD; Steulet C; Burman AL; Danovaro-Holliday MC; Sodha SV; Kretsinger K
    Int J Infect Dis; 2022 Jun; 119():201-209. PubMed ID: 35398300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current regional consensus recommendations on infant vaccination of the Latin American pediatric infectious diseases society (SLIPE).
    Falleiros-Arlant LH; Torres JR; Lopez E; Avila-Agüero ML; Ulloa-Gutierrez R; Mascareñas A; Brea J
    Expert Rev Vaccines; 2020 Jun; 19(6):491-498. PubMed ID: 32580593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of integrated supportive supervision in the context of coronavirus 19 pandemic: its effects on routine immunization and vaccine preventable surveillance diseases indicators in the East and Southern African countries.
    Bello IM; Lebo E; Shibeshi ME; Akpan GU; Chakauya J; Masresha BG; Daniel F
    Pan Afr Med J; 2021; 38():164. PubMed ID: 33995771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of COVID-19 on vaccination programs: adverse or positive?
    Ali I
    Hum Vaccin Immunother; 2020 Nov; 16(11):2594-2600. PubMed ID: 32961081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovation and immunization program management: traceability and quality in Latin America and the Caribbean, laying the groundwork for a regional action plan.
    Tregnaghi P; Ospina-Henao S; Maldonado Oliva C; Bocanegra CL; Toledo C; Aldaz C; Pérez G; Díaz Ortega JL; Castelli JM; Aguilar L; Oliva L; Jiménez Quinteros M; Enriquez Navas M; Arroba R
    Expert Rev Vaccines; 2022 Aug; 21(8):1023-1028. PubMed ID: 35549597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COVID-19 pandemic on the utilization of routine immunization services in Lebanon.
    Mansour Z; Arab J; Said R; Rady A; Hamadeh R; Gerbaka B; Bizri AR
    PLoS One; 2021; 16(2):e0246951. PubMed ID: 33596271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The challenge of changing the inactivated poliomyelitis vaccine in Latin America: declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE).
    Falleiros-Arlant LH; Avila-Agüero ML; Brea del Castillo J; Mariño C
    Rev Chilena Infectol; 2014 Oct; 31(5):590-603. PubMed ID: 25491459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories.
    Shet A; Carr K; Danovaro-Holliday MC; Sodha SV; Prosperi C; Wunderlich J; Wonodi C; Reynolds HW; Mirza I; Gacic-Dobo M; O'Brien KL; Lindstrand A
    Lancet Glob Health; 2022 Feb; 10(2):e186-e194. PubMed ID: 34951973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 outbreak: a potential threat to routine vaccination programme activities in Nigeria.
    Ogundele OA; Omotoso AA; Fagbemi AT
    Hum Vaccin Immunother; 2021 Mar; 17(3):661-663. PubMed ID: 32991237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the COVID-19 pandemic on routine childhood immunisation in Colombia.
    Moreno-Montoya J; Ballesteros SM; Rojas Sotelo JC; Bocanegra Cervera CL; Barrera-López P; De la Hoz-Valle JA
    Arch Dis Child; 2022 Mar; 107(3):e4. PubMed ID: 34285000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region.
    Ortiz JR; Robertson J; Hsu JS; Yu SL; Driscoll AJ; Williams SR; Chen WH; Fitzpatrick MC; Sow S; Biellik RJ; Neuzil KM
    Vaccine; 2021 Apr; 39(15):2165-2176. PubMed ID: 33744049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of Vaccine-Preventable Diseases: The Perfect Storm of Hesitancy, Refusal, a Pandemic, and War.
    McGrath E
    Pediatr Ann; 2022 Nov; 51(11):e426-e430. PubMed ID: 36343179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of vaccine-preventable diseases, trends in vaccine coverage and current challenges in the implementation of the expanded program on immunization: A situation analysis of Cameroon.
    Ngwa CH; Doungtsop BK; Bihnwi R; Ngo NV; Yang NM
    Hum Vaccin Immunother; 2022 Dec; 18(1):1939620. PubMed ID: 34197271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination coverage and preventable diseases in Peru: Reflections on the first diphtheria case in two decades during the midst of COVID-19 pandemic.
    Mezones-Holguin E; Al-Kassab-Córdova A; Maguiña JL; Rodriguez-Morales AJ
    Travel Med Infect Dis; 2021; 40():101956. PubMed ID: 33340773
    [No Abstract]   [Full Text] [Related]  

  • 18. Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020.
    Middeldorp M; van Lier A; van der Maas N; Veldhuijzen I; Freudenburg W; van Sorge NM; Sanders EAM; Knol MJ; de Melker HE
    Vaccine; 2021 Feb; 39(7):1039-1043. PubMed ID: 33478793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covid-19 vaccine management (Comirnaty and mrna-1273 Moderna) in a teaching hospital in Italy: a short report on the vaccination campaign.
    Papini F; Grassi N; Guglielmi G; Gattini V; Rago L; Bisordi C; Scateni M; Totaro M; Tulipani A; Porretta A; Tavoschi L; Guercini J; Luchini G; Briani S; Privitera GP; Baggiani A
    Environ Health Prev Med; 2021 Sep; 26(1):99. PubMed ID: 34592930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of Immunizations during the COVID-19 Emergency.
    Stefanati A; d'Anchera E; De Motoli F; Savio M; Toffoletto MV; Gabutti G
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33477591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 85.